A Nationwide, Population-Based Epidemiology Study of Primary Central Nervous System Tumors in Korea, 2007-2016: A Comparison with United States Data
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Purpose The purpose of this study was to determine the epidemiologic characteristics and survival of patients with primary brain and other central nervous system (CNS) tumors in Korea and to compare our findings with those from the United States. Materials and Methods We collected data on primary brain and CNS tumors diagnosed between 2007 and 2016 from the Korea Central Cancer Registry. The age-standardized incidence rates (ASRs) and 5-year relative survival rates (RSRs) were evaluated. We applied the classification and definitions of the Central Brain Tumor Registry of the United States to our analysis for direct comparison with United States data. Results A total of 115,050 primary brain and CNS tumors were identified, and the ASR of all tumors was 22.01 per 100,000 individuals, which was lower than the 23.41 in the United States. However, the ASR of malignant tumors was significantly lower herein (4.27) than in the United States (7.08). Meningeal tumors were the most common histologic group among all tumors (ASR, 8.32). The 5-year RSR of all primary brain and other CNS tumors was 86.4%, and that of all malignant tumors was 44.1%, which was higher than the 35.8% observed in the United States. Among malignant tumors, glioblastomas had the lowest 5-year RSR (12.1%). Conclusion In Korea, malignant brain and other CNS tumors have a lower incidence and better survival outcome.
Abstract
Purpose The purpose of this study was to determine the epidemiologic characteristics and survival of patients with primary brain and other central nervous system (CNS) tumors in Korea and to compare our findings with those from the United States. Materials and Methods We collected data on primary brain and CNS tumors diagnosed between 2007 and 2016 from the Korea Central Cancer Registry. The age-standardized incidence rates (ASRs) and 5-year relative survival rates (RSRs) were evaluated. We applied the classification and definitions of the Central Brain Tumor Registry of the United States to our analysis for direct comparison with United States data. Results A total of 115,050 primary brain and CNS tumors were identified, and the ASR of all tumors was 22.01 per 100,000 individuals, which was lower than the 23.41 in the United States. However, the ASR of malignant tumors was significantly lower herein (4.27) than in the United States (7.08). Meningeal tumors were the most common histologic group among all tumors (ASR, 8.32). The 5-year RSR of all primary brain and other CNS tumors was 86.4%, and that of all malignant tumors was 44.1%, which was higher than the 35.8% observed in the United States. Among malignant tumors, glioblastomas had the lowest 5-year RSR (12.1%). Conclusion In Korea, malignant brain and other CNS tumors have a lower incidence and better survival outcome.
참고문헌 (26)
- Fritz A, "International Classification of Diseases for Oncology (ICD-O)" (2000), World Health Organization
- Ostrom QT, "CBTRUS statistical report : primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016", Neuro Oncol, 21, pp.v1~100 (2019)
- Altekruse SF, "SEER cancer statistics review, 1975-2007" (2010), National Cancer Institute
- 이창현, "Epidemiology of Primary Brain and Central Nervous System Tumors in Korea", 대한신경외과학회지, 48(2), pp.145~152 (2010), 대한신경외과학회
- 정규원, "An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea", Brain Tumor Research and Treatment, 1(1), pp.16~23 (2013), 대한뇌종양학회
- 도윤식, "An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea, 2013", Brain Tumor Research and Treatment, 5(1), pp.16~23 (2017), 대한뇌종양학회
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016", Cancer Research and Treatment, 51(2), pp.417~430 (2019), 대한암학회
- "Korean Statistical Information Service" (2019)[URL]
- Kaneko S, "Trend of brain tumor incidence by histological subtypes in Japan : estimation from the Brain Tumor Registry of Japan, 1973-1993", J Neurooncol, 60, pp.61~69 (2002)
- Wohrer A, "The Austrian Brain Tumour Registry : a cooperative way to establish a population-based brain tumour registry", J Neurooncol, 95, pp.401~411 (2009)
- Sant M, "Survival of European patients with central nervous system tumors", Int J Cancer, 131, pp.173~185 (2012)
- Jazayeri SB, "Epidemiology of primary CNS tumors in Iran : a systematic review", Asian Pac J Cancer Prev, 14, pp.3979~3985 (2013)
- de Robles P, "The worldwide incidence and prevalence of primary brain tumors : a systematic review and metaanalysis", Neuro Oncol, 17, pp.776~783 (2015)
- Chien LN, "Comparative brain and central nervous system tumor incidence and survival between the United States and Taiwan based on population-based registry", Front Public Health, 4, pp.151~ (2016)
- Miranda-Filho A, "Cancers of the brain and CNS : global patterns and trends in incidence", Neuro Oncol, 19, pp.270~280 (2017)
- Darlix A, "Epidemiology for primary brain tumors : a nationwide population-based study", J Neurooncol, 131, pp.525~546 (2017)
- Lin YJ, "Trends in the incidence of primary malignant brain tumors in Taiwan and correlation with comorbidities : a populationbased study", Clin Neurol Neurosurg, 159, pp.72~82 (2017)
- Pouchieu C, "Increasing incidence of central nervous system(CNS)tumors(2000-2012) : findings from a population based registry in Gironde(France)", BMC Cancer, 18, pp.653~ (2018)
- Nakamura H, "Epidemiological study of primary intracranial tumors : a regional survey in Kumamoto prefecture in southern Japan--20-year study", Int J Clin Oncol, 16, pp.314~321 (2011)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- Woehrer A, "Relative survival of patients with non-malignant central nervous system tumours : a descriptive study by the Austrian Brain Tumour Registry", Br J Cancer, 110, pp.286~296 (2014)
- Ward E, "Cancer disparities by race", ethnicity and socioeconomic status, 2004, pp.54, 78~93
- Woehrer A, "Brain tumour epidemiology in Austria and the Austrian brain tumour registry", Clin Neuropathol, 32, pp.269~285 (2013)
- Bruhn H, "Improved survival of Swedish glioblastoma patients treated according to Stupp", Acta Neurol Scand, 138, pp.332~337 (2018)
- Glied S, "The future of the affordable care act and insurance coverage", Am J Public Health, 107, pp.538~540 (2017)
- Thakkar JP, "Epidemiologic and molecular prognostic review of glioblastoma", Cancer Epidemiol Biomarkers Prev, 23, pp.1985~1996 (2014)